COVID-19 Tanılı Klinik ve Yoğun Bakım Hastalarında ABO ve Rh Kan Grup Antijenlerinin Mortalite ile İlişkisi: Bir Pandemi Hastanesi Deneyimi
Abstract
Keywords
References
- 1.Tsang HF, Chan LWC, Cho WCS, et al. An update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention and treatment strategies. Expert Rev Anti Infect Ther 2021;19(7):877-88.
- 2.Latz CA, DeCarlo C, Boitano L, et al. Blood type and outcomes in patients with COVID-19. Ann Hematol 2020;99(9):2113-18.
- 3.Vasan SK, Rostgaard K, Majeed A, et al. ABO Blood Group and Risk of Thromboembolic and Arterial Disease: A Study of 1.5 Million Blood Donors. Circulation 2016;133(15):1449-57.
- 4.Solmaz İ, Araç S. ABO blood groups in COVID-19 patients; Cross-sectional study. Int J Clin Pract 2021;75(4).
- 5.Hosoi E. Biological and clinical aspects of ABO blood group system. J Med Invest 2008 Aug;55(3-4):174-82.
- 6.Cheng Y, Cheng G, Chui CH, et al. ABO blood group and susceptibility to severe acute respiratory syndrome. JAMA 2005;293(12):1450-1.
- 7.Zhao J, Yang Y, Huang H, et al. Relationship between the ABO Blood Group and the COVID-19 Susceptibility. Clin Infect Dis 2021;73(2):328-31.
- 8.Göker H, Aladağ Karakulak E, Demiroğlu H, et al. The effects of blood group types on the risk of COVID-19 infection and its clinical outcome. Turk J Med Sci 2020;50(4):679-83.
Details
Primary Language
Turkish
Subjects
Intensive Care
Journal Section
Research Article
Authors
Serra Topal
*
0000-0003-3431-0472
Türkiye
Gülbahar Çalışkan
0000-0002-0053-9087
Türkiye
Ayça Sayan
0000-0001-7047-5464
Türkiye
Publication Date
March 31, 2023
Submission Date
June 13, 2022
Acceptance Date
March 16, 2023
Published in Issue
Year 2023 Volume: 10 Number: 1